Latest principal investigator Stories
MISSISSAUGA, ON, Nov. 18 /PRNewswire/ - YM BioSciences Inc. (NYSE Amex: YMI, TSX: YM), today reported that the Phase I/II clinical trial for its orally available JAK1/JAK2 inhibitor, CYT387, in patients with myelofibrosis has been expanded to five sites.
Experts concerned that inadequate treatment strategies make cancer patients suffer unnecessarily.
NASA released today this stunning image of the Heart and Soul nebulae.
NASA's Wide-field Infrared Survey Explorer, or WISE, has spotted its first never-before-seen near-Earth asteroid, the first of hundreds it is expected to find during its mission to map the whole sky in infrared light.
NASA's current mission in orbit around the moon, the Lunar Reconnaissance Orbiter, or LRO, has been providing crucial insights about our nearest celestial neighbor since its launch in June.
GREENBELT, Md., Dec. 15 /PRNewswire-USNewswire/ -- NASA's current mission in orbit around the moon, the Lunar Reconnaissance Orbiter, or LRO, has been providing crucial insights about our nearest celestial neighbor since its launch in June.
NASA will hold a NASA Science Update at 2:15 p.m. EDT on Thursday, Oct. 15, to discuss new science data of our galaxy obtained from the agency's Interstellar Boundary Explorer, or IBEX, spacecraft. NASA Television and the agency's Web site will provide live coverage of the briefing from the James E. Webb Memorial Auditorium at NASA Headquarters, 300 E St. SW, in Washington.
Rui Costa, principal investigator of the Champalimaud Neuroscience Program at the Institute Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants
The latest findings of the North Carolina-Louisiana Prostate Cancer Project reveal potential new targets for reducing racial disparities in prostate cancer survival and highlight the importance of the health care delivery system.
A study by researchers from the University of California, San Diego School of Medicine, in collaboration with Mexican researchers and health officials, shows that as many as 67 percent of injection drug users in Tijuana test positive for tuberculosis (TB) infection.